Understanding how CHD4 affects the development and function of insulin-producing cells in the pancreas
CHD4-MEDIATED TRANSCRIPTIONAL REGULATION OF PANCREATIC BETA CELL DEVELOPMENT AND FUNCTION
This study is looking at how a protein called CHD4 helps make insulin-producing cells from stem cells, which could lead to better treatments for diabetes by providing a steady supply of these important cells.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10857304 on NIH RePORTER |
What this research studies
This research investigates the role of the CHD4 protein in the development and function of pancreatic beta cells, which are crucial for insulin production. By exploring how CHD4 influences the transcriptional networks involved in differentiating human pluripotent stem cells into functional beta-like cells, the study aims to improve current methods for generating insulin-producing cells. This could potentially lead to better treatments for diabetes by creating a reliable source of transplantable beta cells. The research employs advanced techniques such as ChIP sequencing to analyze gene regulation and cellular processes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes, particularly those who may benefit from islet transplantation or improved insulin therapies.
Not a fit: Patients who do not have diabetes or those whose diabetes is not amenable to islet transplantation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved methods for generating insulin-producing cells, providing new treatment options for diabetes patients.
How similar studies have performed: Previous research has shown promise in differentiating stem cells into insulin-producing cells, but this study aims to refine and enhance those methods, making it a novel approach.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Sarbaugh, Dylan — University of Colorado Denver
- Study coordinator: Sarbaugh, Dylan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.